Builoff, Valerie
Lemley, Mark
Miller, Robert J. H.
Fujito, Hidesato
Ramirez, Giselle
Kavanagh, Paul
Buckley, Christopher
Di Carli, Marcelo
Berman, Daniel S.
Slomka, Piotr https://orcid.org/0000-0002-6110-938X
Funding for this research was provided by:
Cedars-Sinai Medical Center
Article History
Received: 2 December 2024
Accepted: 18 February 2025
First Online: 5 March 2025
Declarations
:
: The study complied with the Declaration of Helsinki, and Institutional Review Board approval was obtained at each site.
: All patients enrolled in the phase III trial provided written informed consent.
: The authors affirm that human research participants provided informed consent for publication of the images in Fig. 3 and Supplemental Fig. 5.
: DB, PS, and PK participate in software royalties for QPS software at Cedars-Sinai Medical Center. PS received grant support from Siemens and Synektik. DB served as a consultant for GE Healthcare. RM has received consulting fees and research support from Pfizer. MDC has received research grant support from Spectrum Dynamics and consulting honoraria from Sanofi and GE Healthcare. CB is an employee of GE Healthcare. All other authors have no disclosures.